Myelin heterogeneity for assessing normal appearing white matter myelin damage in multiple sclerosis

Conventional MRI measures of multiple sclerosis (MS) disease severity, such as lesion volume and brain atrophy, do not provide information about microstructural tissue changes, which may be driving physical and cognitive progression. Myelin damage in normal‐appearing white matter (NAWM) is likely an important contributor to MS disability. Myelin water fraction (MWF) provides quantitative measurements of myelin. Mean MWF reflects average myelin content, while MWF standard deviation (SD) describes variation in myelin within regions. The myelin heterogeneity index (MHI = SD/mean MWF) is a composite metric of myelin content and myelin variability. We investigated how mean MWF, SD, and MHI compare in differentiating MS from controls and their associations with physical and cognitive disability.

[1]  C. Laule,et al.  Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis , 2021, Multiple sclerosis.

[2]  C. Granziera,et al.  Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging , 2021, Brain : a journal of neurology.

[3]  A. MacKay,et al.  An atlas for human brain myelin content throughout the adult life span , 2021, Scientific reports.

[4]  Adam V. Dvorak,et al.  Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis , 2020, JAMA Network Open.

[5]  D. Reich,et al.  Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy , 2020, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[6]  Cornelia Laule,et al.  Myelin water imaging to detect demyelination and remyelination and its validation in pathology , 2018, Brain pathology.

[7]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[8]  S. Razavi,et al.  Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy , 2016, Cell journal.

[9]  A. MacKay,et al.  Magnetic Resonance of Myelin Water: An in vivo Marker for Myelin , 2016, Brain plasticity.

[10]  Gareth J. Barker,et al.  Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker , 2015, NeuroImage: Clinical.

[11]  Alex L. MacKay,et al.  Rapid whole cerebrum myelin water imaging using a 3D GRASE sequence , 2012, NeuroImage.

[12]  Craig K. Jones,et al.  Applications of stimulated echo correction to multicomponent T2 analysis , 2012, Magnetic resonance in medicine.

[13]  Roger C. Tam,et al.  Optimizing the Use of Radiologist Seed Points for Improved Multiple Sclerosis Lesion Segmentation , 2010, IEEE Transactions on Biomedical Engineering.

[14]  P. Calabresi,et al.  MRI of the corpus callosum in multiple sclerosis: association with disability , 2010, Multiple sclerosis.

[15]  Piotr Kozlowski,et al.  Myelin water imaging of multiple sclerosis at 7 T: Correlations with histopathology , 2008, NeuroImage.

[16]  A. MacKay,et al.  Magnetic resonance imaging of myelin , 2007, Neurotherapeutics.

[17]  S. Nelson,et al.  Multislice Brain Myelin Water Fractions at 3T in Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[18]  C. Laule,et al.  Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology , 2006, Multiple sclerosis.

[19]  P. Szeszko,et al.  MRI atlas of human white matter , 2006 .

[20]  C. Laule,et al.  Water content and myelin water fraction in multiple sclerosis , 2004, Journal of Neurology.

[21]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[22]  R. Feise.  Do multiple outcome measures require p-value adjustment? , 2002, BMC medical research methodology.

[23]  J Zhang,et al.  Some statistical methods for multiple endpoints in clinical trials. , 1997, Controlled clinical trials.

[24]  Alex L. MacKay,et al.  Quantitative interpretation of NMR relaxation data , 1989 .

[25]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[26]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[27]  I. Allen,et al.  A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis , 1979, Journal of the Neurological Sciences.

[28]  T. Fog,et al.  [Multiple sclerosis; review]. , 1954, Maanedsskrift for praktisk laegegerning og social Medicin.

[29]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.